
    
      -  A medical data collection survey sheet will be filled out by the patient or doctor with
           medical information pertaining to how the patient responded to rituximab and other
           monoclonal antibodies for use in this study.

        -  Blood work will be performed to analyze the blood by molecular technology to find the
           kind of Fc gamna RIIIa receptor the patient possess and correlate these findings with
           the outcome of treatment with rituximab or other monoclonal antibodies.
    
  